1.
Ali Murat Kahveci, Veysel Tahan. Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies . Turkish Journal of Gastroenterology [Internet]. 2019 Jul. 25 [cited 2025 Jul. 6];27(1):89-90. Available from: https://turkjgastroenterol.avesjournals.com/index.php/tjg/article/view/3228